Provider review
Zealthy review
Quotes the branded drugs at an insurance copay and the cash route separately.
Both paths priced on one page — a copay figure and a four-digit cash figure for the same drugs. That gap is the most important fact about branded pricing and most sellers leave you to find it alone.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Zealthy
Branded as low as $25/mo with insurance; four figures without it
FDA warning letter · Zealthy · September 2025 · addressed to FitRX, LLC dba Zealthy. Details in our review.
- Vs median
- Not comparable — the figure is an insurance copay outcome rather than a price the provider sets, so it depends on a plan we cannot read
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The useful thing here is that both paths appear on the same page. Zealthy quotes the branded GLP-1s at an insurance copay and also shows what the same drugs cost without coverage, and the distance between those two numbers — a couple of tens against a couple of thousands — is the single most important fact about branded GLP-1 pricing, and the one most sellers leave a reader to discover on their own after signing up. Seeing it set out plainly is worth the visit even if you end up going elsewhere. Read the small number correctly, though. It is a copay outcome that depends entirely on a plan you have to check yourself; it is not a price this provider sets or can promise, and putting it in the headline invites a reader to plan around a figure that may not apply to them at all. A promotional discount runs across the program with the usual absence of any standing rate beside it, so what the program costs after the promotion is unstated. And as almost everywhere on this site, no dose sits behind any figure. One piece of context added after this review first went up: this brand runs on a shared telehealth platform, and two others reviewed here run on the same one with the same prices. White-labeling is ordinary in this industry and implies nothing about the standard of care. It is worth knowing only so that agreement between those three is not mistaken for independent confirmation.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have insurance and want to see what the branded drugs cost under it.
- You want the insured and uninsured paths priced side by side.
- You want all four branded GLP-1s available from one provider.
Look elsewhere if
- You are uninsured and anchoring on the headline. That figure is a copay outcome.
- You want to know the post-promotion rate. No standing figure is published.
- You are pricing a dose. None is published behind any figure.
What it actually costs
Price as published
Branded Ozempic, Wegovy, Zepbound and Mounjaro quoted "as low as $25/month" with insurance, alongside a cash route and a $1,349 figure for the branded product without coverage · a "limited time: $96 off" promotion runs across the weight-loss program, and a $151 figure appears against the program itself · ★ the site is explicit that it serves patients "with or without insurance" and prices both paths rather than assuming one, which is more useful than the usual silence · the $25 headline is an insurance copay outcome, not a price — what a reader actually pays depends on their own plan, and the same page carries a four-figure number for the same drugs without it · no dose is published behind any figure · ADDED 2026-08-12 AFTER PUBLICATION: its pricing, its FAQ and 27 verbatim sentences are IDENTICAL to two other brands reviewed here, Roen Rx and FitRx, each of which carries its own copyright and presents as an independent company — so comparing the three confirms nothing
- Vs median
- Not comparable — the figure is an insurance copay outcome rather than a price the provider sets, so it depends on a plan we cannot read
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Both molecules are carried as branded products, but the headline figure is an insurance COPAY outcome rather than a price the provider sets, and the cash figure beside it is four digits. Neither is readable as a rate a reader can plan on without checking their own plan first. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Prices both the insured and the uninsured path on the same page rather than one.
- Carries all four branded GLP-1s rather than a single product.
- States plainly that it serves patients with or without insurance.
Pharmacy, labs and oversight
Zealthy dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Zealthy publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Zealthy in September 2025. It is addressed to FitRX, LLC dba Zealthy — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Zealthy is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
The useful thing here is that both paths are priced on the same page. Zealthy quotes the branded GLP-1s at an insurance copay and also shows what they cost without coverage, and the gap between those two numbers — a couple of tens against a couple of thousands — is the single most important fact about branded GLP-1 pricing and the one most sellers leave a reader to discover on their own. Seeing it laid out is worth the visit even if you go elsewhere. Read the small number correctly though. It is a copay outcome that depends entirely on a plan you have to check yourself, not a price this provider controls or can promise, and quoting it as a headline invites a reader to plan around a figure that may not apply to them at all. A promotional discount runs across the program with the usual absence of a standing rate beside it. And as almost everywhere on this site, no dose sits behind any figure. One thing was established only after this review first published, and it matters more than the pricing: this brand shares its prices, its FAQ and twenty-seven complete sentences word for word with two others reviewed here, each presenting as an independent company. Comparing them against each other confirms nothing at all.
The honest cons
The headline figure is an insurance copay outcome, not a price the provider sets.
- The promotional discount has no standing rate published beside it.
- No dose is published behind any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Zealthy is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#216 of 373
Ordered with the companies that pay us first, and Zealthy is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.